A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma


Kose M., Sufliarsky J., Beslija S., Saip P., Tulunay G., Krejcy K., ...More

GYNECOLOGIC ONCOLOGY, vol.96, pp.374-380, 2005 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 96 Issue: 2
  • Publication Date: 2005
  • Doi Number: 10.1016/j.ygyno.2004.10.011
  • Title of Journal : GYNECOLOGIC ONCOLOGY
  • Page Numbers: pp.374-380

Abstract

Objectives. Gemcitabine and carboplatin each have demonstrated effectiveness without increased neurotoxicity in pretreated patients with ovarian cancer. We evaluated the efficacy and safety of gemcitabine plus carboplatin in patients with recurrent ovarian cancer in a multicenter phase II study.